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Abstract
We reviewed 80 adult cases of measles seen in a Parisian hospital
during the French 2010–2011 outbreak. Fifty per cent had at least
one complication: pneumonia and hepatitis were the most
frequent. Forty per cent of hospitalized cases did not have any
complications, suggesting clinically poor tolerance of measles in
adults. The outcome was always favourable. Subjects were younger,
were more often French nationals and had a higher socio-economic
status than the overall population. This report suggests that
immunity resulting from natural disease in patients from an area
where the disease is endemic is protective in the long term.
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Introduction
The measles vaccine was introduced into the French immu-
nization schedule in 1983 as a single dose, leading to a sharp
decrease in the measles incidence rate in France (below 0.1
per 100 000 people in 2006–2007) [1]. However, the vacci-
nation coverage has not reached the 95% needed to eradicate
the disease [2]. Since late 2008, the number of measles cases
has increased dramatically in France, with 22 000 cases
notiﬁed, 15 000 of which occurred in 2011, mainly in young
adults and adolescents [3]. The objective of this study was to
describe the socio-demographic proﬁle, clinical pattern and
complications related to measles cases seen in a northern
Parisian teaching hospital during this 2010–2011 outbreak.
Methods
We retrospectively reviewed all measles cases seen in the
general or the infectious disease emergency rooms of the
Bichat-Claude Bernard Hospital from 1 January 2010 to 31
December 2011. Conﬁrmed cases were deﬁned as patients
presenting with fever and generalized rash for >3 days, and in
whomthediagnosis ofmeasleswas conﬁrmedby the presenceof
measles-speciﬁc IgM antibodies in serum (RT-PCRs were not
performed).
Demographic and clinical data were collected through a
review of paper and electronic medical records with a
standard questionnaire. All clinical symptoms and biochemical
abnormalities were recorded. Pneumonia was deﬁned as the
presence of clinical signs and chest X-ray abnormalities. The
diagnosis of bacterial pneumonia was made according to the
clinician evaluation. Hepatitis was deﬁned as an increase in
alanine aminotransferase levels to >2.5 the upper limit of
normal value. Severity of hepatitis was then graduated
according to the ANRS scale (version No. 1.0) [4]. In addition,
we performed a case–control study comparing the
socio-demographic characteristics of the measles cases with
a random sample of patients hospitalized in our infectious
disease department over the same period for other causes.
Results
From January 2010 to December 2011, a total of 80 conﬁrmed
cases of measles were included in this study; none was related
to nosocomial transmission.
The majority of selected patients (41%) sought care
between January and August 2011, which corresponded to
the national peak of the epidemic. The median age of enrolled
patients was 27 years (range, 22.75–31.25 years), and the
male/female sex ratio was 0.6. No patient had underlying
immunosuppressive disease. Fifty patients (62.5%) had an
unknown vaccination status. Among the 30 remaining patients,
only ten (33%) had been vaccinated against measles, and two of
them had received two injections.
Clinical and biochemical data are reported in Table 1. All
patients had fever and rash according to the case deﬁnition.
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The median delay between fever and rash was 3 days
(interquartile (IQ)25–75: 2–5 days). Seventy patients (87.5%)
had coryza, and 37 (46%) had digestive symptoms such as
nausea, vomiting, or diarrhoea. Lymphopenia below 1.5 g/L
was found in 65 cases (81.2%), with an average total
lymphocyte count of 873/mm3 (IQ25–75: 460–900/mm
3). In
22 patients, measles-speciﬁc IgG antibodies were positive
(33.8%); four of these were vaccinated. Half of the cases had at
least one complication. Hepatitis was the most frequent, with
30 recorded cases (37.5%). None had liver failure. Pneumonia
was the second most frequent complication, being recorded in
25 cases (31%). Nineteen cases (76%) were considered to be
related to the virus alone. We considered that pneumonia was
related to a bacterial infection in six cases (24%) although
bacterial documentation was not available. Three of 25
patients (12%) had to be transferred to the intensive-care
unit for severe hypoxaemia. None of these patients received
antiviral treatment. Encephalitis was not observed in our study.
Measles outcome was always favourable (100%).
Sixty-seven patients (84%) were hospitalized. The mean
duration of hospitalization was 4.6  1.6 days. Forty patients
were hospitalized for at least one complication.
The 67 measles inpatients who were compared with the
control inpatients during the same period in our department
were signiﬁcantly younger than controls (28 vs. 44 years;
p <0.01), were more often employed (25% vs. 10%; p <0.05),
and were more often French nationals (69% vs. 46%; p <0.01).
Fourteen (20.9%) control patients were from sub-Saharan
Africa, and there were no patients from this geographical area
among the measles cases.
Discussion
In developed countries, measles can be seen whatever the
patient’s age.
This study reports 80 cases of measles in adults seen in our
institution from January 2010 to December 2011 during the
French 2010–2011 epidemic outbreak. Interestingly, 67 of the
80 patients had to be hospitalized, and 40% of them had no
complications, which indicates poor clinical tolerance of
measles in young adults (median age, 27 years; range, 22.75–
31.25 years). This is in agreement with the study of Yasunaga
et al. [5], who reported a high proportion of hospitalizations in
patients aged 15–30 years, despite the fact that complications
were observed in only 13% of subjects.
We found a high proportion of patients with biological
hepatitis (37.5% of all cases). This has been described
previously in young adults [3,6,7]. The second most frequent
complication in our study was pneumonia, which occurred in
31% of our cases, which is in agreement with the
proportions given in previous reports [3,8,9]. As previously
noted [10], patients with pneumonia often needed oxygen
therapy (72%). Because of a lack of microbiological docu-
mentation, the proportion of bacterial superinfections may
have been overestimated (24%), although our estimates
remain lower than those reported in developing countries
[8,9].
The case–control study that we conducted highlights the
fact that the measles cases seen in our hospital had a higher
socio-economic status than controls, who were also less
often French nationals. Our clinical centre is particularly
involved in the medical care of immigrants. The absence of
measles case among people from sub-Saharan Africa suggests
that immunity resulting from natural disease in patients from
an area where the disease is endemic is protective in the long
term.
As previously reported, measles vaccinal coverage needs to
be improved in France [11], and the current vaccine schedule
efﬁcacy might be incomplete [12]. The clinical ﬁndings of this
study of measles in 80 adults highlight the poor tolerance but
the absence of severe complications of the disease.
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TABLE 1. Clinical featuresandcomplicationsofmeaslescases
Clinical features No. (%) of patients
Fever + rash 80 (100)
Coryza 70 (87.5)
Digestive symptoms 37 (45)
Complications
All 40 (50)
Hepatitis 30 (37.5)
Grade 2 9 (11.3)
Grade 3 19 (23.8)
Grade 4 2 (2.5)
Pneumonia 25 (31)
Viral 19 (23.8)
Bacterial superinfection 6 (7.5)
Oxygen dependence 18 (22.5)
Transfer to ICU 3 (3.8)
Pancreatitis 2 (2.5)
Favourable outcome 80 (100)
ICU, intensive-care unit.
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